Jinhai Med Tech Reports Narrowed Annual Loss of SGD 17.08 Million

Stock News03-28

Jinhai Med Tech (02225) announced its financial results for the year ended December 31, 2025. The group recorded revenue of SGD 46.276 million, a decrease of 7.89% compared to the previous year. The loss attributable to the company's owners was SGD 17.08 million, which represents a reduction of 4.9% year-on-year. The loss per share was SGD 0.33 cents.

According to the announcement, the group incurred a total loss of SGD 17.4 million for the 2025 fiscal year, compared to a loss of SGD 18.3 million in the 2024 fiscal year. This reduction in the overall loss was primarily due to a decrease in administrative expenses of SGD 7.5 million, which was partially offset by a decline in gross profit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment